Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwak, MH[Kwak, Min Hwan] | - |
dc.contributor.author | Lee, MW[Lee, Min Woo] | - |
dc.contributor.author | Ko, SE[Ko, Seong Eun] | - |
dc.contributor.author | Rhim, H[Rhim, Hyunchul] | - |
dc.contributor.author | Kang, TW[Kang, Tae Wook] | - |
dc.contributor.author | Song, KD[Song, Kyoung Doo] | - |
dc.contributor.author | Kim, JM[Kim, Jong Man] | - |
dc.contributor.author | Choi, GS[Choi, Gyu-Seong] | - |
dc.date.accessioned | 2022-06-15T01:41:59Z | - |
dc.date.available | 2022-06-15T01:41:59Z | - |
dc.date.created | 2022-06-15 | - |
dc.date.issued | 2022-07 | - |
dc.identifier.issn | 2288-5919 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/97781 | - |
dc.description.abstract | Purpose: Radiofrequency ablation is a curative treatment option for very early-stage or early-stage hepatocellular carcinoma (HCC). However, percutaneous radiofrequency ablation (PRFA) for subphrenic tumors is technically challenging. Laparoscopic radiofrequency ablation (LRFA) has been used to overcome this disadvantage. This study compared the treatment outcomes between LRFA and PRFA for subphrenic HCC. Methods: This retrospective study screened patients who underwent PRFA or LRFA for subphrenic HCC between 2013 and 2018. Therapeutic outcomes, including local tumor progression (LTP), intrahepatic distant recurrence (IDR), extrahepatic metastasis (EM), disease-free survival (DFS), and overall survival (OS), were compared between the two groups. Results: Thirty patients in the PRFA group and 23 patients in the LRFA group were included. LTP was observed in six patients in the PRFA group (20%), but in no patients in the LRFA group. The cumulative LTP rates at 1, 3, and 5 years were 3.7%, 23.4%, and 23.4%, respectively, in the PRFA group and 0.0% in the LRFA group (P=0.015). The IDR, EM, and DFS rates were not significantly different between the two groups (P=0.304, P=0.175, and P=0.075, respectively). The OS rates at 1, 3, and 5 years were 96.6%, 85.7%, and 71.6%, respectively, in the PRFA group and 100%, 95.7%, and 95.7%, respectively, in the LRFA group (P=0.049). Conclusion: LRFA demonstrated better therapeutic outcomes than did PRFA for subphrenic tumors in terms of LTP and OS. Therefore, LRFA can be considered as the first-line treatment option for subphrenic HCC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC ULTRASOUND MEDICINE | - |
dc.subject | DIAPHRAGM | - |
dc.subject | SAFETY | - |
dc.title | Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kwak, MH[Kwak, Min Hwan] | - |
dc.contributor.affiliatedAuthor | Lee, MW[Lee, Min Woo] | - |
dc.contributor.affiliatedAuthor | Rhim, H[Rhim, Hyunchul] | - |
dc.contributor.affiliatedAuthor | Kang, TW[Kang, Tae Wook] | - |
dc.contributor.affiliatedAuthor | Song, KD[Song, Kyoung Doo] | - |
dc.contributor.affiliatedAuthor | Kim, JM[Kim, Jong Man] | - |
dc.identifier.doi | 10.14366/usg.21241 | - |
dc.identifier.scopusid | 2-s2.0-85133667761 | - |
dc.identifier.wosid | 000798797600001 | - |
dc.identifier.bibliographicCitation | ULTRASONOGRAPHY, v.41, no.3, pp.543 - 552 | - |
dc.relation.isPartOf | ULTRASONOGRAPHY | - |
dc.citation.title | ULTRASONOGRAPHY | - |
dc.citation.volume | 41 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 543 | - |
dc.citation.endPage | 552 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | DIAPHRAGM | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordAuthor | Radiofrequency ablation | - |
dc.subject.keywordAuthor | Laparoscopy | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | Diaphragm | - |
dc.subject.keywordAuthor | Local tumor progression | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.